AstraZeneca: all 4,196 studies
Page 26 of 42. Open to participants first (299), then studies with results posted, then the rest; newest registration first within each.
- Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD0284 in Healthy SubjectsCompletedNCT02976831Phase 1
- Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal InsulinsCompletedNCT02974244
- A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCLActive, not recruitingNCT02972840Phase 3
- Study With DapagliflozinCompletedNCT02971618
- A Study to Evaluate the Disposition of Drug in Body and Safety After Administration of Single Inhaled Doses of Drugs Abediterol and AZD7594 Administered Alone, in Fixed Dose Combination and in Free Combination Using the Dry Powder Inhaler in Healthy Male ParticipantsCompletedNCT02967159Phase 1
- A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release TabletCompletedNCT02963116Phase 1
- Irritable Bowel Syndrome Survey in Gastroenterological Adult Outpatients in ChinaCompletedNCT02955316
- A Study to Assess the Effect of AZD5634 on Mucociliary Clearance, Safety, Tolerability and Pharmacokinetic Parameters in Patients With Cystic FibrosisCompletedNCT02950805Phase 1
- Assessment of the Safety, Tolerability and Pharmacodynamics After Administration of One Dose of AZD8601 to Male Patients With Type II Diabetes Mellitus (T2DM)CompletedNCT02935712Phase 1
- A Study to Assess How Much Drug Reaches the Blood When Given From Symbicort pMDI With Spacer Compared to That of Symbicort pMDI Without Spacer in Healthy VolunteersCompletedNCT02934607Phase 1
- Gefitinib Long-term Survivor StudyTerminatedNCT02932345
- A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics (PK) After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy VolunteersCompletedNCT02928354Phase 1
- Screening for Lysosomal Acid Lipase DeficiencyTerminatedNCT02926872
- Study to Assess Osimertinib in Patients w/ Adv Solid Tumours & Normal Kidney Function or Severe Kidney ImpairmentCompletedNCT02923947Phase 1
- Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal ImpairmentCompletedNCT02917057
- Study to Assess the Effect of Osimertinib (TAGRISSO™ ) on Blood Levels of Fexofenadine in Patients With EGFRm+ NSCLCCompletedNCT02908750Phase 1
- Study to Evaluate the Safety and Pharmacokinetics of MEDI9090 in Subjects With Advanced Solid TumorsCompletedNCT02900157Phase 1
- Lesinurad/Allopurinol 200/300 FDC Tablets BioequivalenceCompletedNCT02888054Phase 1
- Non-interventional Study of COPD Patients With Asthma Overlap Syndrome in Viet Nam and TaiwanCompletedNCT02878252
- Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®)CompletedNCT02859129Phase 1
- Economic Outcomes of EQW (Exenatide Once Weekly) vs. IG (Insulin Glargine) in T2D Patients Who Are New to Injectable TherapyCompletedNCT02843399
- Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes NowTerminatedNCT02835599
- AZD4076 in Type 2 Diabetic Subjects With Non-Alcoholic Fatty Liver Disease.CompletedNCT02826525Phase 1
- Real World Assessment of Clinical Outcome Changes -Including Month of Ramadan-for Dapagliflozin in Management of Type II Diabetes MellitusCompletedNCT02805361
- Dapagliflozin Patient Satisfaction SurveyCompletedNCT02805283
- Latin American Study of 24-hs Symptoms in Chronic Obstructive Pulmonary Disease (COPD) Patients; LASSYC StudyCompletedNCT02789540
- AZD2014 Plus Novel Anti-Cancer Agents in Relapsed or Refractory Diffuse Large B-Cell LymphomaWithdrawnNCT02780830Phase 1
- PANORAMA - Real World Molecular Testing, Treatment Patterns, and Clinical Outcomes EGFR Mutation-Positive NSCLCCompletedNCT02777658
- KOREA Study (Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy)CompletedNCT02777567
- Observational Study of Obstructive Lung Disease (NOVELTY)CompletedNCT02760329
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of AZD9567.CompletedNCT02760316Phase 1
- Tagrisso Tablets Clinical Experience Investigation (All Case Investigation)CompletedNCT02756039
- A Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With Type 2 Diabetes MellitusTerminatedNCT02749435
- A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid MalignanciesCompletedNCT02740985Phase 1
- A Study of Acalabrutinib in Combination With Rituximab Versus Ibrutinib Versus Acalabrutinib in Subjects With Relapsed or Refractory Mantle Cell LymphomaWithdrawnNCT02735876Phase 3
- Epidemiology of Breast Cancer in Women Based on Diagnosis Data From Oncologists and Breast Surgeons in AlgeriaCompletedNCT02733601
- National Lung Cancer Registry in Men and Women Based on Diagnosis in AlgeriaCompletedNCT02725892
- Effect of DapagliFLOzin on Quality of Life in Patients With Type 2 Diabetes in a Real Clinical PrActiceWithdrawnNCT02719132Phase 4
- A Study of Acalabrutinib in Combination With Rituximab + (Bendamustine or Venetoclax) in Subjects With MCLActive, not recruitingNCT02717624Phase 1
- A Study to Assess the Safety and Tolerability of Single and Multiple Doses of AZD4831 in Healthy Male SubjectsTerminatedNCT02712372Phase 1
- A Study to Evaluate MEDI0562 in Combination With Immune Therapeutic Agents in Adult Subjects With Advanced Solid TumorsCompletedNCT02705482Phase 1
- Complications of UTI in Patients on DapagliflozinCompletedNCT02695173
- Cancer in Patients on Dapagliflozin and Other Antidiabetic TreatmentCompletedNCT02695121
- Acute Liver Injury in Patients on DapagliflozinCompletedNCT02695095
- Acute Kidney Injury in Patients on Dapagliflozin and Other Antidiabetic MedicationsCompletedNCT02695082
- Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERDCompletedNCT02670642Phase 3
- Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid TumorsCompletedNCT02658214Phase 1
- Asthma Control, Quality of Life and Emotional Feelings in a Real Life SettingCompletedNCT02640742
- Safety, Tolerability and Pharmacokinetics of AZD1775 (Adavosertib) Plus MEDI4736 (Durvalumab) in Patients With Advanced Solid TumoursCompletedNCT02617277Phase 1
- "Me and My Heart" StudyCompletedNCT02615704
- A Study to Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male SubjectsCompletedNCT02612662Phase 1
- Phase Ib Study to Determine MTD of AZD1775 Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumours.CompletedNCT02610075Phase 1
- RDEA3170 PK/PD StudyCompletedNCT02608710Phase 1
- REal World EVidence for TrEAtment of HyperkaLemia in Emergency Department: Multicenter, Prospective, Observational StudyCompletedNCT02607085
- Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease.CompletedNCT02606851
- Egypt Hypertension StudyCompletedNCT02604771
- A Non-interventional Study to Investigate the Current Situation of Asthma-COPD Overlap Syndrome in Patients Over Age 40 With Persistent Airflow Limitation in ChinaCompletedNCT02600221
- Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast CancerCompletedNCT02599714Phase 1
- A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban FormulationsCompletedNCT02596100Phase 1
- Study to Understand Usage and Effect of Saxagliptin as First Add-On After Metformin in Indian Type 2 Diabetes Mellitus PatientsCompletedNCT02588859
- Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced CancerCompletedNCT02588105Phase 1
- A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid TumoursCompletedNCT02586987Phase 1
- A Study in Adult Subjects With Select Advanced Solid TumorsCompletedNCT02583165Phase 1
- Lesinurad/Allopurinol 200/300 FDC Tablets BioavailabilityCompletedNCT02581553Phase 1
- A Phase I Study of Safety, Tolerability, and PK of AZD2811 in Patients With Advanced Solid Tumors.CompletedNCT02579226Phase 1
- Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus on SGLT 2 Inhibitor Therapy in SingaporeCompletedNCT02578563
- A Phase 1/2 Study of MEDI4276 in Adults Subjects With Select HER2-expressing Advanced Solid Tumors.CompletedNCT02576548Phase 1
- Effectiveness of Statins on Lipid Goal Attainment and Lipid Parameters in PCI PatientsWithdrawnNCT02561845
- A Study to Compare the Pharmacokinetics of Different Formulations of AZD9977 and the Influence of Food in Healthy Male SubjectsWithdrawnNCT02560363Phase 1
- A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative Radiation in Subjects With Solid TumorsTerminatedNCT02556463Phase 1
- DETECT-Register DocumEnTation and Evaluation of a COPD Combination TherapyCompletedNCT02552160
- MEDI4736 Alone and in Combination With Tremelimumab or AZD9150 in Adult Subjects With Relapsed/Refractory DLBCL (D4190C00023)CompletedNCT02549651Phase 1
- Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder CancerActive, not recruitingNCT02546661Phase 1
- SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)CompletedNCT02543476
- A Phase 1, Single- and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MEDI4166 in Subjects With Type 2 DiabetesCompletedNCT02524782Phase 1
- AZD1775 Combined With Olaparib in Patients With Refractory Solid TumorsCompletedNCT02511795Phase 1
- A Study of MEDI7352 in Painful Osteoarthritis of the KneeCompletedNCT02508155Phase 1
- MEDI9447 Alone and in Combination With MEDI4736 in Adult Participants With Select Advanced Solid Tumors.CompletedNCT02503774Phase 1
- C-PATROL - Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer PopulationCompletedNCT02503436
- Expanded Access Program for Asfotase Alfa Treatment for Patients With Infantile- or Juvenile-onset Hypophosphatasia (HPP)Approved for marketingNCT02496689
- Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid TumoursCompletedNCT02482311Phase 1
- Nexium Capsules S-CEI for Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Based on Patient Clinical OutcomesCompletedNCT02477475
- Survey on the Treatment Reality of Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-small Cell Lung Cancer(NSCLC)CompletedNCT02475720
- Congenital Malformations and Maternal Use of Anti-hypertensive Medication in the United KingdomCompletedNCT02459990
- AZD9291 US Expanded Access ProgramNo longer availableNCT02451852
- ICS/LABA Adherence and COPD ExacerbationCompletedNCT02446041
- Evaluation on the Safety of Ticagrelor Among Chinese ACS PatientsCompletedNCT02430493
- High Risk Populations Among COPD Patients in JapanCompletedNCT02413359
- An Observational Prospective Study to Understand the Usage Pattern of Ticagrelor With ACS (Acute Coronary Syndrome)CompletedNCT02408224
- Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian CancerCompletedNCT02406235
- TAURAS - T790 AURA ScreenFailure SOC Registry StudyTerminatedNCT02405247
- Japanese Phase I Study of AZD2014 in Advanced Solid MalignanciesCompletedNCT02398747Phase 1
- IVIVR Assessing PK Parameters Used to Establish BioequivalenceCompletedNCT02398448Phase 1
- A Phase 1, Single Dose Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Healthy VolunteersCompletedNCT02394314Phase 1
- DECT Study in Allopurinol-Treated Gout PatientsCompletedNCT02393560
- Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes MutationsWithdrawnNCT02392676Phase 3
- An Expanded Access Protocol for Sebelipase Alfa for Patients With Lysosomal Acid Lipase DeficiencyNo longer availableNCT02376751
- T790M Mutation Positive 2nd Line STandard of cAre RegistryWithdrawnNCT02368990
- Non-inteRvEntional Study to Observe rAtionaLe to Select add-on TherapY for Type 2 Diabetes Inadequately Controlled With Metformin.CompletedNCT02355145
- Phase 1 Placebo-controlled,Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of MEDI8852 in AdultsCompletedNCT02350751Phase 1